Skip to main
Ulysseus Science
Communities
My dashboard
New upload
New community
Log in

A

ALLANORE Y

Last name: ALLANORE Y

    Recent uploads

  • 2017 (v1)
    Publication
    Metadata-only
    An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey).
    Ingegnoli F Ughi N Dinsdale G

    To canvas opinion concerning the role of non-invasive techniques in the assessment of patients with Raynaud's phenomenon (Rp) in clinical and research settings: four nailfold capillaroscopy methods [videocapillaroscopy (NVC), dermoscopy, stereomicroscopy, digital USB microscopy], four laser Doppler methods (laser Doppler flowmetry, imaging,...

    Uploaded on: April 14, 2023
  • 2022 (v1)
    Publication
    Metadata-only
    Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
    Vanhaecke A Cutolo M Distler O

    No description

    Uploaded on: February 11, 2024
  • 2020 (v1)
    Publication
    Metadata-only
    Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.
    Allanore Y Bozzi S Terlinden A

    No description

    Uploaded on: April 14, 2023
  • 2014 (v1)
    Publication
    Metadata-only
    Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis
    Minier T Guiducci S Bellando-Randone S

    The EULAR (European League Against Rheumatism) Scleroderma Trials and Research Group (EUSTAR) has identified preliminary criteria for very early diagnosis of systemic sclerosis (SSc). Our aim was to assess the prevalence of each proposed diagnostic item in a large observational patient cohort with Raynaud's phenomenon (RP).

    Uploaded on: May 13, 2023
  • 2023 (v1)
    Publication
    Metadata-only
    Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region.
    Lescoat A Huscher D Schoof N

    No description

    Uploaded on: January 31, 2024
  • 2009 (v1)
    Publication
    Metadata-only
    The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
    Matucci Cerinic M Allanore Y Czirják L

    No description

    Uploaded on: April 14, 2023
  • 2022 (v1)
    Publication
    Metadata-only
    Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
    Garaiman A Steigmiller K Gebhard C

    Objective To develop and validate the prognostic prediction model DU-VASC to assist the clinicians in decision-making regarding the use of platelet inhibitors (PIs) for the management of digital ulcers in patients with systemic sclerosis. Secondly, to assess the incremental value of PIs as predictor. Methods We analysed patient data from the...

    Uploaded on: February 11, 2024
  • 2022 (v1)
    Publication
    Metadata-only
    Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort.
    Zanatta E Huscher D Ortolan A

    No description

    Uploaded on: February 4, 2024
  • 2015 (v1)
    Publication
    Metadata-only
    Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.
    Hachulla E Clerson P Airò P

    No description

    Uploaded on: April 14, 2023
  • 2011 (v1)
    Publication
    Metadata-only
    "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.
    Cappelli S Bellando Randone S Martinović D

    MCTD is a distinct clinical entity but it is evident that a subgroup of patients may evolve into another CTD during disease progression. Initial clinical features and autoantibodies can be useful to predict disease evolution.

    Uploaded on: April 14, 2023
  • 2022 (v1)
    Publication
    Metadata-only
    Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.
    Kuster S Jordan S Elhai M

    No description

    Uploaded on: February 4, 2024
  • 2011 (v1)
    Publication
    Metadata-only
    Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.
    Distler JH Jordan S Airo P

    No description

    Uploaded on: April 14, 2023
  • 2018 (v1)
    Publication
    Metadata-only
    Systemic sclerosis: state of the art on clinical practice guidelines
    Smith V Scirè CA Talarico R

    Systemic sclerosis (SSc) is an orphan disease characterised by autoimmunity, fibrosis of the skin and internal organs, and vasculopathy. SSc may be associated with high morbidity and mortality. In this narrative review we summarise the results of a systematic literature research, which was performed as part of the European Reference Network on...

    Uploaded on: March 27, 2023

About Ulysseus

Main website

Join our research network

Match4Cooperation

Powered by InvenioRDM